EPISODE · Oct 16, 2024 · 36 MIN
Platform Technology in Pediatrics with Rhaeos’ Anna Lisa Somera
from Impact1 Voices · host Impact1 at Stanford Biodesign
Anna Lisa Somera is the CEO of Rhaeos, a company developing the FlowSense device to assess hydrocephalus shunt flow in pediatric and adult patients. In this episode, Anna Lisa discusses how her team chose to use their platform sensor technology to meet the needs of hydrocephalus patients and clinicians. She also addresses the benefits of family involvement in clinical trials, opportunities for non-dilutive funding, and resources outside of Silicon Valley.
Embed this episode
Ready to play
Platform Technology in Pediatrics with Rhaeos’ Anna Lisa Somera
No transcript for this episode yet
Similar Episodes
No similar episodes found.